Hims Subscription Explained: How the Recurring GLP-1 Membership Works

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables behind every metabolic decision. Browse all Peptides & GLP-1 education

What follows is an independent editorial review. PlexusDx holds no commercial relationship with Hims or its parent company, and nothing here involves affiliate links or paid placement.

Searches for Hims as a subscription usually come from people trying to understand the recurring-billing side of GLP-1 telehealth: what auto-renews, what a membership actually buys, and how easy it is to stop. This review walks through the subscription mechanics, the medication behind them, and one variable the recurring model never bills you for. Fair-balance framing, current as of April 2026.

How the Hims subscription is structured

Hims (Hims & Hers Health) runs on a recurring telehealth membership rather than a one-time visit. In this model a licensed provider reviews your intake, and if you qualify a prescription is issued and then renewed on a set cadence so medication ships without a new appointment each cycle. Confirm the current renewal terms on Hims's official website.

What a recurring GLP-1 membership includes

A subscription in this category typically bundles four moving parts into one recurring charge: the clinical evaluation, the prescription itself, fulfillment through either a retail pharmacy (for FDA-approved brand products) or a 503A compounding pharmacy (for compounded semaglutide or tirzepatide), and ongoing follow-up for titration and side-effect check-ins. The intake captures weight, medical history, and current medications before anything renews.

What drives the monthly charge

Because the model is subscription-based, the number you see reflects product choice, tier, and whether the pharmacy pathway is branded or compounded rather than a single flat fee. Across the telehealth GLP-1 market as of April 2026, all-in monthly totals commonly land somewhere between roughly $200 and $700+, with wide variance. Treat any figure as provisional and verify it on Hims's official website before subscribing — these numbers move often.

The evidence behind the medication a subscription ships

Whatever the billing cadence, the pharmacology comes from the compound class: GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, and the GIP/GLP-1 dual agonist tirzepatide. The pivotal programs are STEP (semaglutide for weight management, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Trial populations and endpoints differ, and individual outcomes vary.

The genetic layer no subscription bills for

A recurring plan renews the prescription; it never reads the metabolic biology underneath it. Variants in FTO (fat-mass and obesity-associated), GLP1R (the GLP-1 receptor itself, the target of every GLP-1 compound), MC4R (a melanocortin receptor central to satiety), and TCF7L2 (linked to glucose homeostasis and GLP-1 secretion) map the terrain any compound acts on. They are pathway-level context — they do not predict response to a specific drug, but they describe the biology a clinician is prescribing into.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What differs is the upstream context: before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, MC4R, and TCF7L2 — so a subscription decision starts from your baseline biology, not guesswork. That is the test before you invest approach.

Not affiliated: PlexusDx has no affiliation or commercial relationship with Hims or the companies referenced here.

Related reading on PlexusDx: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs.

Disclaimer: This editorial review is for information only. PlexusDx is not affiliated with Hims and dispenses semaglutide and tirzepatide through its own Weight Management Protocols; this piece compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: see the Weight Management Protocols, or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions

Can a Hims subscription be canceled?

Recurring telehealth memberships generally allow cancellation, but renewal windows, shipping cutoffs, and refund rules differ by program and can affect an already-processed cycle. Review the current cancellation terms and billing cadence directly on the brand's own website before you enroll, since these policies change over time.

Does the subscription fee include the medication?

It depends on the tier. Some plans fold the clinical fee and medication into one recurring charge, while others separate them, and branded versus compounded fulfillment shifts the total. Across the telehealth GLP-1 market as of April 2026, monthly totals commonly range from roughly $200 to $700+. Verify current pricing on the brand's site.

Is compounded semaglutide in a subscription legitimate?

Compounded semaglutide or tirzepatide dispensed through a state-licensed 503A compounding pharmacy on a valid prescription is a recognized pathway, distinct from FDA-approved branded products. Legitimacy hinges on licensed clinicians, a licensed pharmacy partner, and clinical evaluation before prescribing. Confirm credentialing on the brand's own site before subscribing.

How does genetic testing fit a subscription decision?

It sits upstream of it. The Precision Peptide Genetic Test does not predict how you will respond to any subscription or compound; it maps pathway-level variants in FTO and MC4R, and TCF7L2 that shape your baseline GLP-1 and energy-balance biology — context that stays relevant no matter which service renews the prescription.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.